[HTML][HTML] Covid-19 and the cardiovascular system: a comprehensive review
RB Azevedo, BG Botelho, JVG Hollanda… - Journal of human …, 2021 - nature.com
Cardiac injury in patients infected with the novel Coronavirus (COVID-19) seems to be
associated with higher morbimortality. We provide a broad review of the clinical evolution of …
associated with higher morbimortality. We provide a broad review of the clinical evolution of …
[HTML][HTML] Emerging treatment strategies for COVID-19 infection
M Gavriatopoulou, I Ntanasis-Stathopoulos… - Clinical and …, 2021 - Springer
The new type of coronavirus (COVID-19), SARS-CoV-2 originated from Wuhan, China and
has led to a worldwide pandemic. COVID-19 is a novel emerging infectious disease caused …
has led to a worldwide pandemic. COVID-19 is a novel emerging infectious disease caused …
COVID-19, immune system response, hyperinflammation and repurposingantirheumatic drugs
Abstract In the Wuhan Province of China, in December 2019, the novel coronavirus 2019
(COVID-19) has caused a severe involvement of the lower respiratory tract leading to an …
(COVID-19) has caused a severe involvement of the lower respiratory tract leading to an …
[HTML][HTML] ESCMID COVID-19 living guidelines: drug treatment and clinical management
M Bartoletti, O Azap, A Barac, L Bussini… - Clinical microbiology …, 2022 - Elsevier
Abstract Scope In January 2021, the ESCMID Executive Committee decided to launch a new
initiative to develop ESCMID guidelines on several COVID-19-related issues, including …
initiative to develop ESCMID guidelines on several COVID-19-related issues, including …
Early treatment of COVID-19 patients with hydroxychloroquine and azithromycin: a retrospective analysis of 1061 cases in Marseille, France
Abstract Background In France, the combination hydroxychloroquine (HCQ) and
azithromycin (AZ) is used in the treatment of COVID-19. Methods We retrospectively report …
azithromycin (AZ) is used in the treatment of COVID-19. Methods We retrospectively report …
SARS-CoV-2 and the pandemic of COVID-19
MT Adil, R Rahman, D Whitelaw, V Jain… - Postgraduate …, 2021 - academic.oup.com
ABSTRACT SARS-CoV-2 is a virus that is the cause of a serious life-threatening disease
known as COVID-19. It was first noted to have occurred in Wuhan, China in November 2019 …
known as COVID-19. It was first noted to have occurred in Wuhan, China in November 2019 …
[HTML][HTML] Outcomes of hydroxychloroquine usage in United States veterans hospitalized with Covid-19
Background Despite limited and conflicting evidence, hydroxychloroquine, alone or in
combination with azithromycin, is widely used in COVID-19 therapy. Methods We performed …
combination with azithromycin, is widely used in COVID-19 therapy. Methods We performed …
[HTML][HTML] Mortality outcomes with hydroxychloroquine and chloroquine in COVID-19 from an international collaborative meta-analysis of randomized trials
Substantial COVID-19 research investment has been allocated to randomized clinical trials
(RCTs) on hydroxychloroquine/chloroquine, which currently face recruitment challenges or …
(RCTs) on hydroxychloroquine/chloroquine, which currently face recruitment challenges or …
COVID-19 and solid organ transplantation: a review article
The coronavirus pandemic has significantly impacted solid organ transplantation (SOT).
Early in the outbreak period, transplant societies recommended suspending living kidney …
Early in the outbreak period, transplant societies recommended suspending living kidney …
[HTML][HTML] Treatment with hydroxychloroquine, azithromycin, and combination in patients hospitalized with COVID-19
S Arshad, P Kilgore, ZS Chaudhry, G Jacobsen… - International journal of …, 2020 - Elsevier
Abstract Significance The United States is in an acceleration phase of the COVID-19
pandemic. Currently there is no known effective therapy or vaccine for treatment of SARS …
pandemic. Currently there is no known effective therapy or vaccine for treatment of SARS …